Bahrain vs Zambia: Share of E. coli infections resistant to cephalosporins
Bahrain
63.0%
in 2022
Zambia
76.5%
in 2022
Bahrain rank
9th
Zambia rank
6th
Share of E. coli infections resistant to cephalosporins over time
- Bahrain
- Zambia
How they compare
Zambia currently reports 76.5% against 63.0% in Bahrain, a difference of 13.5%.
That makes Zambia's figure about 1.2 times Bahrain's.
Across all 5 years both countries report, Zambia has been ahead every year.
Bahrain ranks 9th and Zambia ranks 6th of 46 countries.
Zambia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bahrain | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 51.9% | 57.5% | 5.5% | Zambia |
| 2020s | 59.9% | 88.4% | 28.4% | Zambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Bahrain or Zambia?
- Zambia, at 76.5% against 63.0% in Bahrain as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Bahrain and Zambia?
- 13.5%, with Zambia ahead.
- How many years of comparable data are there for Bahrain and Zambia?
- 5 years are reported by both, from 2017 to 2022.
- How do Bahrain and Zambia rank globally for share of e. coli infections resistant to cephalosporins?
- Bahrain ranks 9th and Zambia ranks 6th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).